Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNcc Regulatory News (NCC)

Share Price Information for Ncc (NCC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 133.00
Bid: 132.80
Ask: 133.20
Change: 1.80 (1.37%)
Spread: 0.40 (0.301%)
Open: 131.60
High: 133.00
Low: 130.20
Prev. Close: 131.20
NCC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

2 Dec 2020 07:00

RNS Number : 1885H
NCC Group PLC
02 December 2020
 

2 December 2020

NCC Group plc

Trading Update

NCC Group plc ("the Group"), the global experts in cyber and software resilience, today publishes a trading update, based on unaudited financial information, for the six months to 30 November 2020.

Trading has remained resilient since the Group's AGM trading statement and, compared to the same period last year, revenue is expected to be slightly ahead.

The Board now believes Adjusted EBIT for the full year will be around the upper end of market expectations,1 although the ongoing challenges of the pandemic mean that there is still a range of possible outcomes for the full financial year.

The Group will report its interim results for the six months to 30 November 2020 on 4 February 2021.

Adam Palser, CEO, commented:

 "Achieving revenue growth in the first six months of the year is a tribute to the inspirational work and dedication shown by my NCC Group colleagues across the world. We are proud to have continued delivering exceptional work for our clients despite the logistical challenges of Covid-19 restrictions. We continue to be excited about the future growth potential of the cyber services market and the opportunity for NCC Group to play a full part in keeping our customers safe and secure."

This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation.

Enquiries

NCC Group (www.nccgroupplc.com)

+44 (0)161 209 5432

Adam Palser, CEO/Tim Kowalski, CFO

Maitland/AMO

 

+44 (0)20 7379 5151

Sam Cartwright

 

1 Market consensus range for Adjusted EBIT FY2021 (Pre-IFRS16) as at 2 December 2020 is £24.5m to £33.3m (Consensus £27.9m). Going forward, Adjusted EBIT will be reported on a post IFRS 16 basis.

 

About NCC Group plc

NCC Group exists to make the world safer and more secure. As the leading independent global cyber security and resilience advisor, NCC Group is trusted by over 15,000 clients worldwide to protect their most critical assets from the ever-changing threat landscape. With the company's knowledge, experience and global footprint, it is best placed to help businesses identify, assess, mitigate and respond to the evolving cyber risks they face. To support its mission, NCC Group continually invests in research and innovation, and is passionate about developing the next generation of cyber scientists. With around 2,000 colleagues in 12 countries, NCC Group has a significant market presence in North America, continental Europe and the UK, and a rapidly growing footprint in Asia Pacific with offices in Australia, Japan and Singapore.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUPGMGPUPUGMG
Date   Source Headline
2nd May 20247:00 amRNSCapital Markets Event for CSMS
1st May 20248:16 amRNSDirector Declaration
24th Apr 20247:00 amRNSAppointment of Joint Broker
18th Apr 20241:12 pmRNSDirector/PDMR Shareholding
16th Apr 202411:29 amRNSDirector/PDMR Shareholding
15th Apr 20244:04 pmRNSHolding(s) in Company
12th Apr 20241:05 pmRNSHolding(s) in Company
9th Apr 20247:00 amRNSCapital Markets Event for Escode
21st Mar 20244:35 pmRNSDirector Declaration
19th Mar 20241:31 pmRNSDirector/PDMR Shareholding
19th Mar 20249:44 amRNSHolding(s) in Company
12th Mar 20245:35 pmRNSHolding(s) in Company
12th Mar 202412:03 pmRNSHolding(s) in Company
20th Feb 202412:36 pmRNSDirector/PDMR Shareholding
31st Jan 20245:30 pmRNSBlock Listing Six Monthly Return
31st Jan 20243:56 pmRNSTR-1: Holding(s) in Company
29th Jan 20245:45 pmRNSChange of Auditor
25th Jan 20247:00 amRNSUnaudited interim results - period ended 30/11/23
18th Jan 20242:58 pmRNSDirector/PDMR Shareholding
21st Dec 20238:02 amRNSStrategic disposal of DetACT
19th Dec 20234:28 pmRNSDirector/PDMR Shareholding
13th Dec 20231:26 pmRNSDirector/PDMR Shareholding
1st Dec 20234:06 pmRNSDirector/PDMR Shareholding
30th Nov 20231:48 pmRNSResults of the 2023 Annual General Meeting
30th Nov 20237:00 amRNSAGM Trading Statement
21st Nov 20235:09 pmRNSBlock Listing Application
21st Nov 20233:51 pmRNSDirector/PDMR Shareholding
31st Oct 20232:13 pmRNSTotal Voting Rights
31st Oct 202311:44 amRNSDirector/PDMR Shareholding
27th Oct 202312:37 pmRNSDirector/PDMR Shareholder Dealing
24th Oct 20235:10 pmRNSHolding(s) in Company
18th Oct 20232:15 pmRNSDirector/PDMR Shareholding
18th Oct 20232:06 pmRNSDirector/PDMR Shareholding
11th Oct 202312:31 pmRNSHolding(s) in Company
11th Oct 202312:21 pmRNSDirector/PDMR Shareholding
10th Oct 20231:07 pmRNSNotice of Annual General Meeting - 2023
10th Oct 202312:52 pmRNSDirector/PDMR Shareholding
5th Oct 202312:58 pmRNSDirector/PDMR Shareholding
4th Oct 20233:26 pmRNSDirector/PDMR Shareholding
3rd Oct 20232:28 pmRNSHolding(s) in Company
28th Sep 20235:07 pmRNSDirector/PDMR Shareholding
27th Sep 20237:00 amRNSPreliminary unaudited FY 2023 Results
20th Sep 202310:44 amRNSHolding(s) in Company
19th Sep 20233:24 pmRNSDirector/PDMR Shareholding
19th Sep 202311:35 amRNSHolding(s) in Company
19th Sep 202311:31 amRNSHolding(s) in Company
7th Sep 20237:00 amRNSChange to date of Prelim results & trading update
23rd Aug 20232:02 pmRNSHolding(s) in Company
18th Aug 20231:27 pmRNSDirector/PDMR Shareholding
31st Jul 20233:09 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.